000 01247 a2200373 4500
005 20250512062836.0
264 0 _c19871022
008 198710s 0 0 eng d
022 _a0141-9854
024 7 _a10.1111/j.1365-2257.1987.tb01394.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBowcock, S J
245 0 0 _aPyrimethamine in the myeloproliferative disorders: a forgotten treatment?
_h[electronic resource]
260 _bClinical and laboratory haematology
_c1987
300 _a129-36 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aChild
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMyeloproliferative Disorders
_xdrug therapy
650 0 4 _aPolycythemia Vera
_xdrug therapy
650 0 4 _aPyrimethamine
_xadverse effects
650 0 4 _aThrombocythemia, Essential
_xdrug therapy
700 1 _aLinch, D C
700 1 _aMachin, S J
700 1 _aStewart, J W
773 0 _tClinical and laboratory haematology
_gvol. 9
_gno. 2
_gp. 129-36
856 4 0 _uhttps://doi.org/10.1111/j.1365-2257.1987.tb01394.x
_zAvailable from publisher's website
999 _c3627566
_d3627566